| 2012 |
FMNL2 is cotranslationally modified by N-terminal myristoylation, which together with interaction with active Cdc42, is required for proper subcellular targeting to lamellipodia and filopodia tips. Abolition of myristoylation or Cdc42 binding prevents FMNL2 activation and membrane targeting. |
Site-directed mutagenesis (Gly2→Ala to block myristoylation, Cdc42-binding mutants), immunofluorescence, RNAi knockdown |
Current Biology |
High |
22608513
|
| 2012 |
FMNL2 acts as an actin filament elongation factor (not nucleator) in the presence of profilin in vitro, and can capture and elongate filament ends generated by Arp2/3-mediated branching. RNAi-mediated silencing decreases lamellipodia protrusion rate and cell migration efficiency. |
In vitro actin polymerization/TIRF assays with purified proteins, RNAi knockdown with quantitative lamellipodium protrusion and migration assays |
Current Biology |
High |
22608513
|
| 2015 |
Crystal structures of the N-terminal domains of human FMNL1 and FMNL2 in complex with active Cdc42 reveal that Cdc42 contacts all five armadillo repeats of the formin, with specific interactions formed by the Rho-GTPase insert helix. Mutation of three residues in Rac1 confers gain-of-function FMNL2 binding and reconstitutes the Cdc42 phenotype in vivo. FMNL dimerization via a parallel coiled coil creates an umbrella-shaped structure spanning >15 nm with six membrane interaction motifs. |
X-ray crystallography, site-directed mutagenesis of Rac1/Cdc42 switch residues, in vivo functional rescue assays |
Nature Communications |
High |
25963737
|
| 2012 |
N-myristoylation at Gly2 of FMNL2 is required for plasma membrane association and for the induction of cellular morphological changes; replacement of Gly2 with Ala or pharmacological inhibition of N-myristoyltransferase abolishes membrane localization and morphological effects. |
Site-directed mutagenesis (Gly2→Ala), N-myristoylation inhibitor treatment, immunofluorescence in HEK293T cells |
Bioscience, Biotechnology, and Biochemistry |
High |
22790947
|
| 2017 |
FMNL2 and FMNL3 accumulate at the Golgi apparatus in a manner requiring both N-terminal myristoylation and interaction with Cdc42. At the Golgi, they assemble a perinuclear actin meshwork; their depletion by RNAi or CRISPR/Cas9 causes Golgi fragmentation, enlargement of endosomes, defective maturation into late endosomes/lysosomes, and impaired anterograde trafficking of VSV-G to the plasma membrane. |
RNAi, CRISPR/Cas9 knockout, live-cell imaging of VSV-G trafficking, immunofluorescence, myristoylation and Cdc42-binding mutants |
Scientific Reports |
High |
28852060
|
| 2010 |
FMNL2 knockdown in colorectal carcinoma cells induces an epithelial-state transition (cobblestone morphology, upregulation of E-cadherin/α-catenin/γ-catenin, downregulation of vimentin/snail/slug) and abolishes TGF-β-induced invasion and EMT. FMNL2 promotes EMT via TGF-β/Smad3 effectors and in collaboration with MAPK/MEK pathway; MEK inhibitor U0126 abrogates elevated p-MAPK/p-MEK in FMNL2-overexpressing cells. |
shRNA knockdown, overexpression, morphological analysis, Western blotting for EMT markers, kinase inhibitor treatment (U0126, LY294002), TGF-β stimulation assays |
Molecular Cancer Research |
Medium |
21071512
|
| 2017 |
FMNL2 physically interacts with COMMD10 (by Co-IP and GST pull-down) and promotes its ubiquitin-mediated proteasomal degradation. Loss of COMMD10 releases p65 NF-κB from inhibition, allowing nuclear translocation of p65 and activation of the NF-κB pathway to promote CRC invasion and metastasis. |
Co-immunoprecipitation, GST pull-down, in vitro ubiquitination assay, dual-luciferase NF-κB reporter, nuclear fractionation, Western blotting, animal metastasis models |
British Journal of Cancer |
High |
28817833
|
| 2018 |
Cortactin directly binds FMNL2 and cooperatively enhances actin polymerization and recycling endosome motility. This cortactin–FMNL2 interaction is required for invadopodia formation and matrix degradation in colorectal cancer cells; EGF/Cdc42 stimulation further enhances the cortactin–FMNL2 complex to increase invadopodia number and matrix degradation. |
Co-immunoprecipitation, GST pull-down, actin polymerization assays, live-cell imaging of endosome motility, invadopodia formation assays, gelatin matrix degradation assay, in vivo metastasis model |
Cancer Letters |
High |
29374558
|
| 2020 |
FMNL2 directly binds dephosphorylated fascin within filopodia and controls fascin dynamics (phosphorylation state, F-actin binding, localization) at the nanoscale in both 2D and 3D environments, as shown by a fascin FRET biosensor and advanced live-cell imaging. |
FRET-based fascin biosensor, structured illumination microscopy, TIRF-SIM, co-immunoprecipitation, RNAi knockdown, live-cell imaging |
Journal of Cell Biology |
High |
32294157
|
| 2021 |
Induced depletion of Arp2/3 complex (Actr3 knockout) reproducibly increases FMNL2 and FMNL3 formin expression, which correlates with explosive induction of filopodia formation, revealing a compensatory or co-regulatory relationship between branched (Arp2/3) and unbranched (FMNL2/3) actin networks. |
Conditional CRISPR/Cas9 Actr3 knockout (tamoxifen-inducible), immunoblotting, live-cell imaging, quantitative filopodia analysis |
Frontiers in Cell and Developmental Biology |
Medium |
33598464
|
| 2018 |
FMNL2 mediates cell-cell contact formation downstream of Rac1, independently of Cdc42. CRISPR/Cas9 loss of FMNL2 in MCF10A cells impairs intercellular contact establishment; optogenetic Rac1 activation recruits FMNL2 to newly forming junctions, whereas Cdc42 silencing does not affect FMNL2-mediated contact formation. |
CRISPR/Cas9 knockout, optogenetic Rac1 activation, live-cell imaging of junction formation, RNAi, quantitative protrusion analysis |
PLoS ONE |
High |
29579104
|
| 2023 |
FMNL2-dependent rapid filopodia formation requires both N-terminal myristoylation (for filopodia tip localization) and serine 1072 phosphorylation within the DAD domain by PKCα. PKCα localizes to the base of growing filopodia and a PKCα-FMNL2 signaling module spatiotemporally controls filopodia dynamics. |
Structured illumination microscopy, phospho-site mutagenesis (S1072A), PKCα inhibition/knockdown, live-cell imaging, immunofluorescence co-localization |
Biomolecules |
Medium |
36979484
|
| 2021 |
A disease-associated heterozygous FMNL2 p.L136P mutation causes subcellular mislocalization, deregulated autoinhibition (gain-of-function), impaired cell spreading, defective filopodia formation in fibroblasts, and dysregulated podosome formation with defective matrix degradation in THP-1 macrophages. |
Expression of L136P mutant vs. wild-type in patient-derived and model cell lines, immunofluorescence localization, cell spreading assay, filopodia quantification, podosome formation, gelatin degradation assay |
PLoS ONE |
Medium |
34043722
|
| 2022 |
FMNL2 cooperates with the I-BAR domain protein IRTKS (but not IRSp53) to drive filopodia assembly. FMNL2 and IRTKS are mutually dependent cofactors; the primary function of FMNL2 in this process is membrane binding to recruit IRTKS, which then nucleates filopodia assembly, while FH2-mediated actin dynamics is secondary. |
Co-immunoprecipitation, co-expression studies, filopodia quantification, RNAi knockdown of IRTKS/IRSp53, domain mutagenesis |
Journal of Biological Chemistry |
Medium |
36259517
|
| 2024 |
FMNL2 localizes to the oocyte cortex and spindle periphery during meiosis; its depletion reduces cytoplasmic actin polymerization, causes failure of meiotic spindle migration to the cortex, leading to polar body extrusion defects and large polar bodies. FMNL2 also associates with mitochondria and ER-related proteins (by mass spectrometry), and its depletion disrupts mitochondrial membrane potential and causes ER stress. |
Morpholino/siRNA knockdown in mouse and porcine oocytes, live-cell imaging, immunofluorescence, mass spectrometry proteomics, mRNA rescue microinjection, JC-1 mitochondrial membrane potential assay |
eLife |
High |
38747713
|
| 2024 |
Proximity labeling proteomics (BioID) identified an FMNL2 interactome including known partners and novel interactors related to filopodia, lamellipodia, vesicle trafficking, cell junctions, focal adhesions, and extracellular vesicles; FMNL2 protein was directly detected in exosomes. |
BioID proximity labeling, quantitative mass spectrometry proteomics, exosome isolation and Western blotting |
International Journal of Molecular Sciences |
Medium |
38891874
|
| 2025 |
FMNL2 directly interacts with SRC kinase through the FMNL2-FH1 domain and SRC-SH3 domain, and this interaction promotes androgen receptor (AR) translocation from cytoplasm to nucleus, increasing AR target gene expression and driving enzalutamide resistance in prostate cancer cells. |
Co-immunoprecipitation, domain mapping, nuclear fractionation, AR reporter assays, RNAi knockdown, SRC inhibitor (dasatinib) treatment, proliferation assays |
iScience |
Medium |
40212590
|
| 2020 |
CAV1 (Caveolin-1) modulates collective epithelial cell migration by controlling cortical availability of FMNL2; CAV1 depletion increases cortical recruitment of FMNL2, and simultaneous depletion of FMNL2 rescues the migration defect caused by CAV1 RNAi, placing FMNL2 downstream of CAV1 in collective migration. |
RNAi (CAV1 and FMNL2 single and double knockdown), collective migration velocity correlation analysis, immunofluorescence |
Biology of the Cell |
Medium |
33169848
|
| 2022 |
FMNL2 suppresses breast cancer cell migration and invasion by inhibiting the RhoA/LIMK/Cofilin pathway, and this effect is mediated through reduction of cytoplasmic p27. ERα overexpression reduces FMNL2 protein levels via proteasomal degradation (blocked by MG132). |
RNAi knockdown, overexpression, Rho inhibitor (ZOL) and LIMK inhibitor (BMS3) treatment, Western blotting for RhoA/LIMK/Cofilin, cytoplasmic p27 manipulation, MG132 proteasome inhibition, in vivo xenograft |
Cell Death Discovery |
Medium |
35379791
|